Entos announced spin-off company Aegis Life to support global vaccine commercialization

, ,

On Oct. 15, 2020, Entos Pharmaceuticals announces that its San Diego-based spinout company Aegis Life, will pursuing U.S. and international investment to support rapid development of its lead vaccine candidate. As part of a new agreement with Nature Technology Corporation (NTC), Aegis Life and Entos will use NTC’s proprietary Nanoplasmid plasmid DNA technology and manufacturing platform for the clinical and commercial production of theirSARS-CoV-2 vaccine, as well as other DNA vaccine candidates.

Entos’ team of Canadian scientists have developed Fusogenix as a platform to effectively and safely deliver nucleic acid medicines directly inside cells as therapeutics for cancers and other diseases. Fusogenix technology enables researchers to rapidly prototype vaccine candidates and allows for modular, large scale manufacturing, both of which are ideal characteristics for the rapid development of DNA-based vaccines in response to SARS-CoV-2 and other future human pathogenic viruses.

As part of a new agreement with Nature Technology Corporation (NTC), Aegis Life and Entos will use NTC’s proprietary Nanoplasmid™ plasmid DNA technology and manufacturing platform for the clinical and commercial production of their SARS-CoV-2 vaccine, as well as other DNA vaccine candidates. In preclinical studies, NTC’s Nanoplasmid™ vector expressing the SARS-CoV-2 spike protein induced potent humoral immunity, and a durable and balanced cell-mediated response against SARS-CoV-2. The Nanoplasmid™ vector is small, non-immunogenic, and designed to provide optimal expression of genes for vaccine or therapeutic development. It uses a simple sugar for strain selection, making this a superior vector for GMP manufacturing of clinical-stage vaccine candidates.

Tags:


Source: American Association for the Advancement of Science
Credit:

LifeScienceHistory.com offers three advertising package options. Each package lnclude at least two digital images for multiple page placements and maximum exposure! Rates range from just $300 to $500 per month.